ES2052482T3 - Inhibidor de la proliferacion de celulas endoteliales. - Google Patents

Inhibidor de la proliferacion de celulas endoteliales.

Info

Publication number
ES2052482T3
ES2052482T3 ES91905556T ES91905556T ES2052482T3 ES 2052482 T3 ES2052482 T3 ES 2052482T3 ES 91905556 T ES91905556 T ES 91905556T ES 91905556 T ES91905556 T ES 91905556T ES 2052482 T3 ES2052482 T3 ES 2052482T3
Authority
ES
Spain
Prior art keywords
pct
proliferation
inhibitor
endothelial cells
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905556T
Other languages
English (en)
Other versions
ES2052482T1 (es
Inventor
Werner Risau
Hannes Drexler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of ES2052482T1 publication Critical patent/ES2052482T1/es
Application granted granted Critical
Publication of ES2052482T3 publication Critical patent/ES2052482T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PROTEINA QUE ACTUA COMO INHIBIDORA DE LA PROLIFERACION DE CELULAS ENDOTELIALES, OBTENIBLE A PARTIR DE LAS CELULAS DEL HIGADO DE UN BEBE HAMSTER (ATCC CCL 10), LA CUAL EN FILTRACION DE GEL EN CONDICIONES NATIVAS, POSEE UN PESO MOLECULAR ENTRE 60 Y 100 KD, Y MUESTRAN ESTABILIDAD AL CALENTAMIENTO A 60 (GRADOS) C, ASI COMO EL PROCEDIMIENTO PARA SU ENRIQUECIMIENTO Y SU UTILIZACION PARA EL TRATAMIENTO DE ENFERMEDADES.
ES91905556T 1990-03-02 1991-03-01 Inhibidor de la proliferacion de celulas endoteliales. Expired - Lifetime ES2052482T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4006609A DE4006609A1 (de) 1990-03-02 1990-03-02 Inhibitor der proliferation von endothelzellen

Publications (2)

Publication Number Publication Date
ES2052482T1 ES2052482T1 (es) 1994-07-16
ES2052482T3 true ES2052482T3 (es) 1994-08-16

Family

ID=6401295

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905556T Expired - Lifetime ES2052482T3 (es) 1990-03-02 1991-03-01 Inhibidor de la proliferacion de celulas endoteliales.

Country Status (8)

Country Link
US (1) US5286716A (es)
EP (1) EP0517789B1 (es)
JP (1) JPH05504960A (es)
AT (1) ATE106899T1 (es)
DE (2) DE4006609A1 (es)
ES (1) ES2052482T3 (es)
GR (1) GR930300003T1 (es)
WO (1) WO1991013094A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
DE69435342D1 (de) 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-Angiogene Mittel und Verfahren zu deren Verwendung
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
EP0974650A1 (en) * 1998-07-22 2000-01-26 University Of Ioannina/Medical School Endothelial cell growth inhibitors
US6563156B2 (en) * 2001-03-15 2003-05-13 Micron Technology, Inc. Memory elements and methods for making same
WO2007030652A2 (en) * 2005-09-08 2007-03-15 University Of Virginia Patent Foundation Methods and compositions for growing adipose stem cells
JP2010505849A (ja) * 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性創傷治癒に有用な方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210719A (en) * 1978-12-29 1980-07-01 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture

Also Published As

Publication number Publication date
GR930300003T1 (en) 1993-04-28
ES2052482T1 (es) 1994-07-16
EP0517789B1 (de) 1994-06-08
JPH05504960A (ja) 1993-07-29
ATE106899T1 (de) 1994-06-15
DE59101882D1 (de) 1994-07-14
DE4006609A1 (de) 1991-09-26
US5286716A (en) 1994-02-15
WO1991013094A1 (de) 1991-09-05
EP0517789A1 (de) 1992-12-16

Similar Documents

Publication Publication Date Title
DK0764209T3 (da) Albuminekspression i gær
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
NO924310L (no) Nevrobeskyttende indolon- og beslektede derivater
ES2085467T3 (es) Composiciones oftalmicas no oxidantes y metodos para conservar y utilizar las mismas.
AU7609687A (en) Agents for the treatment of arthroses
ATE73332T1 (de) Neuartige verwendung von taurolin.
DK0588833T3 (da) Behandling af biomassemateriale
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
FR2491334B1 (es)
NO972559L (no) Nye dipeptid-p-amidinobenzylamider med N-terminale sulfonyl- eller aminosulfonylrester
ES2052482T3 (es) Inhibidor de la proliferacion de celulas endoteliales.
ATE113056T1 (de) Künstliche rezeptor-analoge.
DK0669803T3 (da) Anvendelse af amidoaminer i ophthalmologiske sammensætninger
ATE167690T1 (de) Polyetheramidoamine hydrogele als heparinersatz
ATE120209T1 (de) Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
FI894029A0 (fi) Medel foer fixering av frisyren och foer haorvaord.
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
ATE62599T1 (de) Verwendung einer loesung von alpha-chymotrypsin.
NO162212C (no) Mykoherbicidkonsentrat, herbicid middel og anvendelse derav.
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
MX9201288A (es) Metodo de tratamiento.
NO912387D0 (no) Rent faktor 1-protein, samt fremgangsmaate for fremstilling av proteinet.
SE9403861D0 (sv) Novel medicinal use
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517789

Country of ref document: ES